Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-07-18FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for trazodone hydrochloride by Teva Pharmaceuticals USA, Inc., indicating an update to labeling …
-
FDA approval · 2014-07-18FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
-
FDA approval · 2014-07-18FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for trazodone hydrochloride from Teva Pharmaceuticals USA, Inc. The approval indicates changes to th…
-
FDA approval · 2014-07-18FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for a fluoxetine hydrochloride generic from Lannett Company, Inc.
-
FDA approval · 2014-07-17FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for WELLBUTRIN SR (bupropion hydrochloride) from GlaxoSmithKline, updating the labeling through a su…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-07-17FDA Approved: CITALOPRAM HYDROBROMIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for Citalopram Hydrobromide from Aurobindo Pharma Limited, authorizing the generic product for U…
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for venlafaxine hydrochloride from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-07-17FDA Approved: DOXEPIN HYDROCHLORIDE — Supplemental Application (Endo USA, Inc.)
FDA approved Endo USA, Inc.'s supplemental application for doxepin hydrochloride, updating the previously approved abbreviated new drug appl…
-
FDA approval · 2014-07-17FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for the PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE product from Mylan Pharmaceuticals Inc., in…
-
FDA approval · 2014-07-17FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Amitriptyline Hydrochloride from Aurobindo Pharma Limited, confirming regulatory approval of thi…
-
FDA approval · 2014-07-17FDA Approved: AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for AMITRIPTYLINE HYDROCHLORIDE (Sandoz Inc) under an ANDA, authorizing changes to the approved gene…
-
FDA approval · 2014-07-17FDA Approved: NEFAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for NEFAZODONE HYDROCHLORIDE from Teva Pharmaceuticals USA, Inc.
-
FDA approval · 2014-07-17FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved the supplemental application to approve Pristiq Extended-Release (desvenlafaxine succinate) from Wyeth/Pfizer.
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
FDA approved a supplemental application for venlafaxine hydrochloride (generic) from Dr. Reddy's Laboratories Limited. This action approves …
-
FDA approval · 2014-07-17FDA Approved: IMIPRAMINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved a supplemental application for imipramine hydrochloride by Lupin Pharmaceuticals, confirming continued approval for the generic…
-
FDA approval · 2014-07-17FDA Approved: AMOXAPINE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Amoxapine from Actavis Pharma, Inc., under an ANDA, expanding/sending forward the approval statu…
-
FDA approval · 2014-07-17FDA Approved: PHENELZINE SULFATE — Supplemental Application (Lupin Pharmaceuticals,Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Phenelzine sulfate (ANDA 200181), a generic monoamine oxidase inhibitor use…
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE — Supplemental Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals' supplemental application for a generic venlafaxine product (ANDA 078932). Venlafaxine is indicated…
-
FDA approval · 2014-07-17FDA Approved: AMOXAPINE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for amoxapine from Chartwell RX, LLC, updating the labeling for this generic antidepressant.
-
FDA approval · 2014-07-17FDA Approved: VENLAFAXINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Venlafaxine hydrochloride, a generic venlafaxine product from Aurobindo Pharma Limited.
-
FDA approval · 2014-07-17FDA Approved: FLUOXETINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved the supplemental application for Fluoxetine from Aurobindo Pharma Limited, indicating continued approval of this generic produc…
-
FDA approval · 2014-07-16FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for VIIBRYD (vilazodone hydrochloride) submitted by Allergan, Inc.
-
FDA approval · 2014-07-16FDA Approved: FLUOXETINE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for a generic fluoxetine hydrochloride product from Lannett Company, Inc. The approval authorize…
-
FDA approval · 2014-07-11FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Wellbutrin XL (bupropion hydrochloride) submitted by Bausch Health US LLC.
-
FDA approval · 2014-07-11FDA Approved: TRAZODONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for trazodone hydrochloride (Teva Pharmaceuticals USA, Inc.) under ANDA071525. This action grants ap…